Oncoheroes Biosciences

Oncoheroes Biosciences is a pioneering, privately-held biotech company singularly focused on pediatric oncology drug development. Founded by two fathers personally impacted by childhood cancer, the company employs a capital-efficient, collaborative model to build a diversified pipeline by repurposing or advancing compounds abandoned or underdeveloped for adult indications. With a seasoned leadership team and a world-class Scientific Advisory Board, Oncoheroes aims to prove that a sustainable, dedicated pediatric cancer biotech is both possible and necessary to bridge the significant innovation gap between adult and pediatric oncology.

A capital-efficient, asset-centric model focused on in-licensing or acquiring shelved or repurposable small molecule compounds from industry and academia, then advancing them through pediatric-specific clinical development.

The pediatric oncology drug development space is relatively uncrowded compared to adult oncology, with few companies dedicated exclusively to it. Competition primarily comes from pediatric divisions of large pharmaceutical companies and academic consortia. Oncoheroes's unique positioning as a pure-play, patient-driven biotech and its asset repurposing model differentiate it from both big pharma and discovery-stage biotechs.